Macro-driven ABB stock price forecast suggests resilience against interest rate fluctuations, with defensive industrial exposure attracting long-term institutional capital. Aussie Broadband's (ASX:ABB) stock is up by 5.1% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to investigate if the company's decent financials had a hand to play in the recent price move. Particularly, we will be paying attention to Aussie Broadband's ROE today. However, after years at the top of this niche industry, Intuitive Surgical is encountering competition from players like Medtronic (NYSE: MDT ), which launched the Hugo RAS system in 2021. The company also began US clinical trials this past May for hernia repair and gynecological procedures. Additionally, newer market entrant Johnson & Johnson’s (NYSE: JNJ ) medical device subsidiary, JNJ MedTech, received investigational device exemption approval from the FDA for its robotic surgical system OTTAVA in November; this approval means it can now begin trials. ABB stock price forecast reflects optimism due to the company’s leadership in electrification projects for offshore wind farms. Consensus target raised to $41.20 following new contract wins.